‘Venom: The Last Dance’ Eyes $65M Domestic Launch Box Office Preview

'Venom: Venom: The Last Dance Venom: Sony Pictures Entertainment's logo for "The Last Dance" Even though it appears that The Last Dance's North American release may be the lowest of Sony's prized antihero franchise, it hopes to liven up the October box office this weekend with a domestic debut of $65 million and an international debut of $100 million.

The primary Toxin opened to $80.2 million out of 2018, then a record for October. It lost the crown a year after the fact to Joker ($96.2 million). The subsequent portion, Toxin: Let There Be Carnage made $90 million when it came out in October 2021. This was a big win for Sony and helped theater owners who were still recovering from the pandemic.